Vault-13

EVAXION BIOTECH A/S EVAX

SPONSORED ADS · ADR · CUSIP 29970R204

0 institutional holders -1 vs Q1 2026
—reported value*
0 new 0 added 0 reduced 1 sold out net sold ≈ $4.5m (-1.2m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0510Q4 23: 1Q1 24: 7Q2 24: 7Q3 24: 9Q4 24: 10Q1 25: 2Q2 25: 2Q3 25: 2Q4 25: 1Q1 26: 1Q2 26: 00Q4 23Q2 24Q4 24Q2 25Q4 25Q2 26
Numbers
QuarterHolders
Q4 20231
Q1 20247
Q2 20247
Q3 20249
Q4 202410
Q1 20252
Q2 20252
Q3 20252
Q4 20251
Q1 20261
Q2 20260

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q3 24: 2 bought or addedQ3 24: 2 cut or sold outQ4 24: 3 bought or addedQ4 24: 4 cut or sold outQ4 24Q1 25: 1 bought or addedQ1 25: 9 cut or sold outQ2 25: 0 bought or addedQ2 25: 0 cut or sold outQ2 25Q3 25: 0 bought or addedQ3 25: 0 cut or sold outQ4 25: 0 bought or addedQ4 25: 1 cut or sold outQ4 25Q1 26: 0 bought or addedQ1 26: 0 cut or sold outQ2 26: 0 bought or addedQ2 26: 1 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202422
Q4 202434
Q1 202519
Q2 202500
Q3 202500
Q4 202501
Q1 202600
Q2 202601

Biggest buyers

None

Biggest sellers

Merck & Co., Inc. Sold out -1,214,126-1.2m

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Merck & Co., Inc. 13G · passive investor filed 2025-02-03 20.0% 63.0m 2025-02-03

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported since 1 Apr 2026.

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change